PNC-27 Peptide: A New Frontier in Cancer Treatment?
Pnc 27, a synthetic peptide derived from the p53 protein, targets cancer cells by interacting with the HDM-2 oncoprotein. This binding triggers apoptosis, focusing its effects on malignant cells and minimizing damage to healthy ones. Early studies on various cancers show promising results, although challenges like stability and delivery remain.

